Tofacitinib Tablets

Project Image

Therapeutic Indication

Rheumatoid arthritis
Psoriatic arthritis
Ulcerative colitis
Autoimmune inflammatory disorders
+91 85919 78885

Tofacitinib

Tablet

Tofacitinib is an oral Janus kinase (JAK) inhibitor used in the treatment of autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by modulating the immune response and reducing inflammation, improving joint function and reducing pain and swelling.

Speciality Immunomodulator / JAK Inhibitor
Tags Autoimmune Care | Anti-inflammatory | JAK Inhibitor
Strength
  • 5 mg
Packing Size
  • 10 Tablets

Check all Tablets Range

Click to know More

Mechanism

Tofacitinib inhibits Janus kinase (JAK1 and JAK3) enzymes, which play a key role in cytokine signaling pathways. By blocking these pathways, it reduces immune system activity and inflammation in autoimmune diseases.

Pharmacokinetics

  • Absorption: Rapid oral absorption
  • Metabolism: Hepatic (CYP3A4)
  • Elimination: Urine and feces

Side Effects

  • Headache
  • Nausea
  • Infections
  • Diarrhea
  • Increased cholesterol

Contraindication

  • Hypersensitivity
  • Severe liver disease
  • Active infections

Interaction

  • CYP3A4 inhibitors
  • Immunosuppressants
  • Biologic therapies

Warning and Precautions

  • Monitor infections
  • Regular blood tests required
  • Use cautiously in elderly
  • Avoid live vaccines